PRSO.NASDAQPeraso INC

10-Q: Peraso Q2 2025: Strategic Review Amidst Losses

Sentiment:

Quarterly Report


Peraso Inc. reports reduced net losses and cash burn in Q2 2025, driven by cost cuts and a shift to mmWave products, while actively exploring strategic alternatives including a Mobix Labs acquisition proposal.

Delay expectedThe expiration date of Series C Warrants was extended from May 6, 2025, to August 4, 2025, and then again to December 5, 2025, indicating a delay in their exercise or resolution.
Capital raiseThe company is actively seeking additional financing (debt or equity arrangements) to meet cash requirements for the foreseeable future.Sold 1,270,158 shares of common stock for net proceeds of approximately $1,512,000 through an at-the-market (ATM) offering program during the six months ended June 30, 2025.The company's ability to continue as a going concern is dependent upon its ability to raise additional capital.If additional capital is raised through equity, stockholders would suffer dilution of their equity ownership.If debt financing is engaged, terms may restrict the company's ability to incur additional indebtedness, pay dividends, repurchase stock, or make investments, and may require maintaining specified liquidity or other ratios.
Worse than expectedThe company explicitly states "substantial doubt as to the Company’s ability to continue as a going concern within one year from the date of issuance of these condensed consolidated financial statements."Cash and cash equivalents decreased significantly from $3.344 million at December 31, 2024, to $1.761 million at June 30, 2025.Total net revenue for Q2 2025 decreased by 47.6% year-over-year, primarily due to the discontinuation of the memory IC product line, which previously accounted for a large portion of revenue.The company expects to continue incurring operating losses and cash burn for the foreseeable future, and its existing cash is only projected to meet needs into the fourth quarter of 2025, indicating an urgent need for additional capital.

Summary

  • Peraso Inc. reported a net loss of $1.8 million for the three months ended June 30, 2025, a significant reduction from $4.4 million in the same period of 2024.
  • For the six months ended June 30, 2025, the net loss was $2.3 million, down from $6.5 million in the prior year period.
  • Total net revenue for Q2 2025 decreased by 47.6% to $2.22 million, primarily due to the discontinuation of memory IC product shipments.
  • Product revenue for Q2 2025 was $2.218 million, down 46% year-over-year, while royalty and other revenue plummeted 98% to $2,000.
  • mmWave ICs revenue surged to $1.318 million in Q2 2025 from $127,000 in Q2 2024, and mmWave modules revenue increased to $886,000 from $553,000.
  • The company completed final end-of-life (EOL) shipments of its memory IC products in March 2025, which previously constituted a significant portion of revenue (38% for H1 2025, 86% for H1 2024).
  • Operating expenses decreased substantially, with R&D down 37% to $1.662 million and SG&A down 34% to $1.411 million in Q2 2025.
  • A reversal of $222,600 in severance and software license obligations positively impacted operating expenses in Q2 2025.
  • Cash and cash equivalents stood at $1.761 million as of June 30, 2025, down from $3.344 million at December 31, 2024.
  • Net cash used in operating activities for the six months ended June 30, 2025, was $3.0 million, an improvement from $3.2 million in the prior year period.
  • The company raised approximately $1.512 million in net proceeds from at-the-market (ATM) stock sales during the first six months of 2025.
  • Peraso Inc. received an unsolicited, non-binding proposal from Mobix Labs, Inc. on June 27, 2025, to acquire all outstanding equity for approximately $1.20 per share.
  • The Board of Directors authorized the exploration of strategic alternatives on July 11, 2025, to maximize stockholder value.

Sentiment

Score: 3

Explanation: The company faces significant going concern risks and declining overall revenue due to a product line discontinuation. While cost reductions and mmWave growth are positive, the immediate financial instability and urgent need for capital outweigh these, leading to a low sentiment score. The strategic review and Mobix proposal offer potential upside but are highly uncertain.

Positives

  • Net loss significantly reduced to $1.8 million in Q2 2025 from $4.4 million in Q2 2024, and to $2.3 million for H1 2025 from $6.5 million for H1 2024, indicating improved financial performance.
  • Cash burn from operating activities decreased to $3.0 million for H1 2025 from $3.2 million for H1 2024.
  • Strong growth in mmWave product sales, with mmWave ICs revenue increasing from $127,000 to $1.318 million and mmWave modules revenue increasing from $553,000 to $886,000 in Q2 2025 compared to Q2 2024.
  • Successful cost reduction initiatives led to a 37% decrease in R&D expenses and a 34% decrease in SG&A expenses in Q2 2025.
  • A reversal of $222,600 in software license obligations contributed to lower operating expenses.
  • Regained compliance with Nasdaq's minimum bid price requirement on June 18, 2025.
  • The company is actively exploring strategic alternatives and has received a non-binding acquisition proposal from Mobix Labs, Inc., potentially offering a path to enhanced shareholder value.

Negatives

  • Substantial doubt exists about the company's ability to continue as a going concern, with an accumulated deficit of $179.4 million as of June 30, 2025.
  • Total net revenue for Q2 2025 decreased by 47.6% to $2.22 million, primarily due to the end-of-life of memory IC products.
  • Royalty and other revenue declined by 98% in Q2 2025, indicating reduced income from licensing and engineering services.
  • Gross profit decreased by 54% in Q2 2025, partly due to the absence of higher-margin memory IC product sales.
  • Cash and cash equivalents decreased to $1.761 million as of June 30, 2025, from $3.344 million at December 31, 2024.
  • Existing cash is projected to meet capital needs only into the fourth quarter of 2025, necessitating additional financing.
  • The discontinuation of the memory IC product line, which represented 86% of H1 2024 revenue, will negatively impact future revenues and cash flows.

Risks

  • Inability to continue as a going concern due to recurring losses and insufficient capital, potentially leading to loss of investment for stockholders.
  • Uncertainty regarding the availability and terms of additional capital (debt or equity financing), which could lead to dilution for existing stockholders or restrictive covenants.
  • The strategic review process may not lead to a favorable outcome, could be time-consuming and disruptive, and may not result in any transaction.
  • The unsolicited Mobix Labs, Inc. proposal is non-binding and may not result in a completed transaction, potentially causing business disruption and stock price volatility.
  • Failure to maintain Nasdaq listing requirements, which could lead to delisting and adversely affect stock price and liquidity.
  • Negative impact on future revenues, results of operations, and cash flows due to the discontinuation of the memory product line.
  • Unintended consequences and additional costs from the November 2023 workforce reductions, such as loss of institutional knowledge, decreased morale, and difficulty in attracting/retaining personnel.
  • International trade policies, including tariffs and sanctions, could adversely affect business, increase costs, reduce margins, and impact customer demand.
  • Inflationary pressures may increase costs, including employee compensation, or lead to employee attrition if compensation does not keep pace with inflation.

Future Outlook

The company expects to continue incurring operating losses for the foreseeable future as it secures additional customers and invests in product commercialization. Sales of mmWave products are anticipated to increase in 2025 based on current order backlog and expected production shipments to new customers. Total R&D expenses are expected to decrease in 2025 due to cost reduction initiatives, while SG&A expenses are expected to remain flat or slightly decrease. The company believes existing cash will meet capital needs into the fourth quarter of 2025 and is actively seeking additional financing to address short-term cash needs and support operations.

Management Comments

  • "Our strategy and primary business objective is to be a profitable, IP-rich fabless semiconductor company offering integrated circuits, or ICs, antenna modules and related non-recurring engineering services."
  • "We have pioneered a high-volume mmWave IC production test methodology using standard, low-cost production test equipment. It has taken us several years to refine performance of this production test methodology, and we believe this places us in a leadership position in addressing the operational challenges of delivering mmWave products into high-volume markets."
  • "We expect sales of our mmWave products to increase from a volume and revenue perspective during 2025, based on our current order backlog and the expected commencement of production shipments to new customers."
  • "We expect that total R&D expenses will decrease during 2025 compared with 2024, as a result of our cost reduction initiatives."
  • "We expect that total SG&A expense will remain flat or slightly decrease for the remainder of 2025 compared with 2024, as we continue to manage our SG&A costs."
  • "We believe that our existing cash and cash equivalents as of June 30, 2025 will enable us to meet our capital needs into the fourth quarter of 2025."
  • "We are currently seeking additional financing in order to meet our cash requirements for the foreseeable future."

Industry Context

Peraso Inc. operates in the highly competitive fabless semiconductor industry, specializing in millimeter wave (mmWave) wireless technology for 802.11ad/ay-compliant devices (60 GHz) and 5G-compliant devices (28/39 GHz). The company's strategic shift away from memory IC products, due to foundry discontinuation, positions it to focus entirely on the growing mmWave market. This market is critical for next-generation wireless communications, including high-speed data transfer and 5G infrastructure. The company's emphasis on a proprietary high-volume mmWave IC production test methodology and integrated antenna modules aims to differentiate it in a market where RF amplifier proximity to antennas is crucial for performance. The unsolicited acquisition proposal from Mobix Labs, Inc., another player in the connectivity solutions space, highlights potential consolidation or strategic interest within the broader semiconductor and wireless technology sectors.

Comparison to Industry Standards

  • The company's accumulated deficit of $179.4 million and recurring net losses are significantly below industry standards for profitable semiconductor companies, indicating a challenging financial position.
  • The substantial doubt about the company's ability to continue as a going concern is a critical deviation from the financial stability typically expected of publicly traded companies in the semiconductor sector.
  • While the growth in mmWave ICs and modules is positive, the overall revenue decline due to the discontinuation of the memory IC product line (which represented 86% of H1 2024 revenue) indicates a significant revenue gap that needs to be filled by the mmWave segment to reach industry-comparable revenue scales.
  • The company's cash position of $1.761 million is very low for a fabless semiconductor company, which typically requires substantial capital for R&D, inventory, and market penetration, especially when compared to larger, more established players like Qualcomm or Broadcom, or even smaller, growing peers in the mmWave space that often have stronger balance sheets or access to more robust funding.
  • The company's cost reduction initiatives, while necessary, suggest a struggle to achieve profitability and scale efficiently compared to industry benchmarks, where companies often invest heavily in R&D for long-term growth rather than cutting back due to liquidity concerns.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
Chief Executive OfficerNARonald Glibbery2025-08-07Awarded 25,000 stock options as part of compensation.
Chief Financial OfficerNAJames Sullivan2025-08-07Awarded 25,000 stock options as part of compensation.
Chief Operating OfficerNABradley Lynch2025-08-07Awarded 25,000 stock options as part of compensation.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Stock Incentive Plan AmendmentStockholders approved amendments increasing the number of shares reserved for issuance under the 2019 Stock Incentive Plan by 1,500,000 shares in December 2024.2024-12-31Increases the pool of shares available for equity compensation, potentially impacting future dilution but also enabling attraction and retention of talent.
Reverse Stock SplitA 1-for-40 reverse stock split of common stock and exchangeable shares was effected on January 3, 2024, to maintain Nasdaq listing compliance.2024-01-03Reduced the number of outstanding shares and increased the per-share price, helping to regain Nasdaq minimum bid price compliance. Did not affect proportionate voting rights or other rights.

Legal Proceedings

  • The company is not a party to any legal proceeding that it believes is likely to have a material adverse effect on its condensed consolidated financial position or results of operations.
  • From time to time, the company may be subject to legal proceedings and claims in the ordinary course of business, which could result in significant financial resources expenditure and diversion of management efforts.

Related Party Transactions

  • A family member of one of the company's executive officers is an employee. Compensation expense for this individual was approximately $28,600 for the three months ended June 30, 2025, and $56,100 for the six months ended June 30, 2025.

Stakeholder Impact

  • **Shareholders**: Face substantial dilution risk from potential future equity raises. The going concern warning indicates a high risk of losing most or all of their investment if additional capital is not secured. The strategic review and Mobix proposal offer potential for value maximization but also introduce uncertainty and volatility.
  • **Employees**: Workforce reductions in November 2023 and subsequent terminations have occurred, potentially impacting morale and leading to loss of institutional knowledge. Future cost reduction strategies may include further headcount reductions.
  • **Customers**: The discontinuation of the memory IC product line means existing customers for these products will need to find alternative suppliers. The focus on mmWave products aims to secure new customers and increase shipments, but this transition carries execution risk.
  • **Suppliers**: The company has significant non-cancelable purchase obligations ($3.1 million) for inventory, primarily wafers and substrates, indicating ongoing relationships but also financial commitments.
  • **Creditors**: The going concern warning and need for additional capital pose risks to creditors, as the company's ability to meet its obligations is uncertain without further financing.

Next Steps

  • Increase revenues substantially to generate sustainable operating profit and sufficient cash flows.
  • Secure additional financing through debt or equity arrangements.
  • Implement additional cost reduction strategies if financing efforts are unsuccessful, potentially including reducing headcount and curtailing business activities.
  • Continue to invest in the commercialization of mmWave products.
  • Evaluate the unsolicited, non-binding proposal from Mobix Labs, Inc. as part of the strategic review process.
  • Continue the exploration of strategic alternatives (merger, sale of assets, or other similar transactions) to maximize stockholder value.
  • Pay remaining contractual liabilities of approximately $0.4 million related to software licenses by September 30, 2025.
  • Series C Warrants are set to expire on December 5, 2025, unless further extended or exercised.

Key Dates

DateDescription
2023-11-01Company implemented employee lay-offs and terminated consulting positions (the Reductions) to reduce operating expenses.
2023-12-15Company filed a certificate of amendment to effect a 1-for-40 reverse stock split of common stock.
2024-01-02Canco filed a certificate of amendment to effect a 1-for-40 reverse stock split of exchangeable shares.
2024-01-03Reverse stock split became effective for trading purposes.
2024-02-06Company entered into an underwriting agreement for a public offering of common stock and warrants.
2024-02-08Public offering closed, generating approximately $3.4 million in net proceeds.
2024-08-06Company extended the expiration date of Series B warrants to October 7, 2024.
2024-08-30Company entered into an At The Market Offering Agreement (Sales Agreement) with Ladenburg.
2024-10-03Company further extended the expiration date of Series B warrants to November 8, 2024.
2024-11-05Company entered into inducement offer letter agreements with certain holders of Series B warrants for a warrant inducement offering.
2024-12-10Company increased the maximum aggregate offering amount of common stock issuable under the Sales Agreement to $2,693,527.
2025-01-01Renewed Toronto office lease for a one-year term, ceasing ASC 842 accounting.
2025-01-14Operating lease for corporate headquarters in San Jose, California expired and was not renewed.
2025-01-31Company issued 40,000 unregistered shares of common stock to a service provider.
2025-03-01Finance lease for equipment expired, and the company took ownership of the equipment.
2025-03-31Company fulfilled all outstanding EOL orders for its memory IC products.
2025-04-04Received a letter from Nasdaq indicating non-compliance with the $1 minimum bid price requirement.
2025-05-02Company extended the expiration date of its Series C Warrants from May 6, 2025 to August 4, 2025.
2025-06-18Received notification from Nasdaq of regaining compliance with the minimum bid price requirement.
2025-06-27Confirmed receipt of an unsolicited, non-binding proposal from Mobix Labs, Inc. to acquire all equity.
2025-07-11Board of Directors authorized the exploration of strategic alternatives.
2025-07-31Remaining severance liabilities of approximately $10,000 as of June 30, 2025 were paid.
2025-08-04Company extended the expiration date of its Series C Warrants from August 4, 2025 to December 5, 2025 (subsequent event).
2025-08-07Compensation committee awarded 25,000 stock options each to CEO, CFO, and COO.
2025-08-08Number of outstanding shares of common stock was 6,171,040.
2025-08-13Filing date of the Quarterly Report on Form 10-Q.
2025-09-30Expected payment date for remaining contractual liabilities of approximately $0.4 million related to software licenses.

Recommendation

hold

Peraso Inc. is in a precarious financial position, evidenced by the 'going concern' warning and declining overall revenue due to the discontinuation of its memory product line. While the company has shown progress in reducing net losses and cash burn, and its mmWave product sales are growing, the immediate liquidity concerns and the urgent need for additional capital present significant risks. The ongoing strategic review, including the unsolicited Mobix Labs proposal, introduces a speculative element. A seasoned investor would recognize the high risk associated with the going concern warning but might 'hold' given the potential for a strategic transaction to unlock value, or for the mmWave business to scale rapidly. However, this is a high-risk 'hold' and requires close monitoring of financing efforts and strategic review outcomes. Without a clear path to sustainable profitability or a definitive strategic transaction, the downside risk remains substantial.

Keywords

semiconductor, mmWave, wireless technology, integrated circuits, antenna modules, fabless, Nasdaq, going concern, strategic alternatives, Mobix Labs, capital raise, financial results, Q2 2025, earnings, PRSO

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.